GRIN2A-Related Severe Epileptic Encephalopathy Treated with Memantine: An Example of Precision Medicine
2019 ◽
Vol 09
(04)
◽
pp. 252-257
◽
Keyword(s):
AbstractEpileptic spasm (ES) is one of the seizure types which is difficult to treat. Next-generation sequencing has facilitated rapid gene discovery that is linked to ES and GRIN2A being one of them. Genotype-driven precision medicine is on the horizon and is a targeted treatment approach toward the precise molecular cause of the disease. GRIN2A gene encodes for a subunit of N-methyl-D-aspartate (NMDA) receptor and it has been suggested from in vitro studies and few case reports that memantine, a NMDA receptor antagonist, was shown to reduce seizures in patients with GRIN2A mutations. Here, we describe a patient with a novel GRIN2A mutation and severe drug-resistant ES who became seizure free with memantine.
1990 ◽
Vol 10
(4)
◽
pp. 527-535
◽
Keyword(s):
1992 ◽
Vol 135
(2)
◽
pp. 149-152
◽
1991 ◽
Vol 65
(3)
◽
pp. 454-467
◽
1993 ◽
Vol 69
(4)
◽
pp. 1150-1159
◽
2020 ◽
Vol 21
(7)
◽
pp. 2616
◽
1996 ◽
Vol 75
(2)
◽
pp. 951-957
◽
2006 ◽
Vol 50
(3)
◽
pp. 277-285
◽
2006 ◽
Vol 95
(4)
◽
pp. 2155-2166
◽